ArrowMark Colorado Holdings LLC Trims Position in HealthEquity, Inc. $HQY

ArrowMark Colorado Holdings LLC cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 39.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 231,902 shares of the company’s stock after selling 150,804 shares during the period. ArrowMark Colorado Holdings LLC owned 0.27% of HealthEquity worth $21,977,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. True Wealth Design LLC grew its stake in HealthEquity by 3,522.2% during the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after acquiring an additional 317 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after acquiring an additional 146 shares during the period. AlphaQuest LLC lifted its stake in HealthEquity by 52.2% in the 3rd quarter. AlphaQuest LLC now owns 624 shares of the company’s stock worth $59,000 after purchasing an additional 214 shares in the last quarter. Allworth Financial LP boosted its holdings in HealthEquity by 283.1% in the 2nd quarter. Allworth Financial LP now owns 747 shares of the company’s stock valued at $78,000 after purchasing an additional 552 shares during the period. Finally, SBI Securities Co. Ltd. boosted its holdings in HealthEquity by 25,100.0% in the 2nd quarter. SBI Securities Co. Ltd. now owns 756 shares of the company’s stock valued at $79,000 after purchasing an additional 753 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Stock Up 1.3%

HQY opened at $77.81 on Friday. The business’s fifty day simple moving average is $81.91 and its 200 day simple moving average is $90.39. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $116.65. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. The stock has a market cap of $6.65 billion, a PE ratio of 35.69, a P/E/G ratio of 0.97 and a beta of 0.26.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. The trade was a 1.99% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.50% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on HQY shares. Jefferies Financial Group set a $108.00 price target on shares of HealthEquity in a report on Thursday, February 19th. UBS Group set a $110.00 target price on HealthEquity in a research report on Tuesday, February 17th. Barrington Research restated an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. Barclays dropped their price target on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. Finally, Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Monday, January 19th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $112.00.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.